연구성과로 돌아가기
2021 연구자 정보 (134 / 1146)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Son, Yong (Son, Y) |
Korea Inst Ind Technol, Intelligent Mfg R&D Dept, 113-58 Seohaean Ro, Siheung Si, Gyeonggi Do, South Korea |
|
|
[JCR상위 4.7] Digital Laser Micropainting for Reprogrammable Optoelectronic Applications | SCIE | 4.7 | CHEMISTRY, MULTIDISCIPLINARY;CHEMISTRY, PHYSICAL;MATERIALS SCIENCE, MULTIDISCIPLINARY;NANOSCIENCE & NANOTECHNOLOGY;PHYSICS, APPLIED;PHYSICS, CONDENSED MATTER | maxko@snu.ac.kr;sukjoonhong@hanyang.ac.kr; | ||
|
Suh, Hee Won (Suh, HW) |
Sungkyunkwan Univ SKKU, Sch Adv Mat Sci & Engn, 2066 Seobu Ro, Suwon 16419, Gyeonggi Do, South Korea |
|
|
[JCR상위 4.7] Progressive NO2 Sensors with Rapid Alarm and Persistent Memory-Type Responses for Wide-Range Sensing Using Antimony Triselenide Nanoflakes | SCIE | 4.7 | CHEMISTRY, MULTIDISCIPLINARY;CHEMISTRY, PHYSICAL;MATERIALS SCIENCE, MULTIDISCIPLINARY;NANOSCIENCE & NANOTECHNOLOGY;PHYSICS, APPLIED;PHYSICS, CONDENSED MATTER | chohk@skku.edu; | ||
|
Ahn, Sang Hoon (Ahn, SH) |
Yonsei Univ, Dept Internal Med, Coll Med, Seoul, South Korea Yonsei Univ, Inst Gastroenterol, Dept Internal Med, Coll Med, Seoul, South Korea Severance Hosp, Yonsei Liver Ctr, Seoul, South Korea Yonsei Univ, Dept Internal Med, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea Yonsei Univ Hlth Syst, Severance Hosp, Yonsei Liver Ctr, Seoul, South Korea Yonsei Univ, Inst Gastroenterol, Coll Med, Seoul, South Korea Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea Yonsei Univ Hlth Syst, Severance Hosp, Yonsel Liver Ctr, Seoul, South Korea Yonsei Univ, Coll Med, Dept Internal Med, 50-1 Yonsei Ro, Seoul 03722, South Korea Yonsei Univ, Coll Med, Inst Gastroenterol, Seoul, South Korea Yonsei Univ, Dept Internal Med, Coll Med, 50-1 Yonsei Ro, Seoul 120752, South Korea Yonsei Univ, Dept Internal Med, Coll Med, Seoul 03722, South Korea Yonsei Univ, Inst Gastroenterol, Coll Med, Seoul 03722, South Korea Severance Hosp, Yonsei Liver Ctr, Seoul 03722, South Korea Yonsei Univ, Coll Med, Seoul, South Korea Yonsei Univ, Yonsei Liver Ctr, Dept Internal Med, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea |
AAV-2600-2020 AFM-2603-2022 Q-1055-2018 SANG-HOON, AHN Ahn, Sang Hoon Lee, Jeong-Hoon |
0000-0002-3629-4624 Ahn, Sang Hoon |
[JCR상위 4.8] An episode of detectable serum hepatitis B virus-DNA level does not affect risk of hepatic decompensation among untreated compensated cirrhosis patient with viral load of <2, 000 IU/ml [JCR상위 27.6] Revised Korean Antiviral Guideline Reduces the Hepatitis B-related Hepatocellular Carcinoma Risk in Cirrhotic Patients [JCR상위 59.7] External validation of CAGE-B and SAGE-B scores for Asian chronic hepatitis B patients with well-controlled viremia by antivirals [JCR상위 14.8] The efficacies of entecavir and tenofovir in terms of enhancing prognosis after curative treatment of hepatitis B virus-related hepatocellular carcinoma [JCR상위 5.9] AN EXTERNAL VALIDATION OF FIBROSCAN-AST SCORE (FAST) FOR NON-INVASIVE IDENTIFICATION OF PATIENTS AT RISK OF PROGRESSIVE NON-ALCOHOLIC STEATOHEPATITIS [JCR상위 59.7] Effect of tenofovir alafenamide vs. tenofovir disoproxil fumarate on hepatocellular carcinoma risk in chronic hepatitis B [JCR상위 16.7] Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B [JCR상위 59.7] Validation of risk prediction scores for hepatocellular carcinoma in patients with chronic hepatitis B treated with entecavir or tenofovir [JCR상위 24.3] Liver Stiffness-Based Risk Prediction Model for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease [JCR상위 48.0] Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma [JCR상위 4.8] Safety, efficacy, and pharmacodynamic (PD) activity of 12 weeks treatment with oral RIG-I agonist, inarigivir (IRIG), plus 48 weeks of tenofovir alafenamide in adult patients with chronic hepatitis B: a phase 2 collaboration study [JCR상위 60.8] Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: A Nationwide, Multi-center, Retrospective Cohort Study [JCR상위 19.9] Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trial |
SCIE | 4.8 |
GASTROENTEROLOGY & HEPATOLOGY MEDICINE, GENERAL & INTERNAL GASTROENTEROLOGY & HEPATOLOGY;INFECTIOUS DISEASES;VIROLOGY ONCOLOGY |
beomkkim@yuhs.ac; ksukorea@yuhs.ac; beomkkim@yuhs.ac;lorry-lee@yuhs.ac;sikarue@yuhs.ac;ksukorea@yuhs.ac;DRPJY@yuhs.ac; dh.sinn@samsung.com;ksukorea@yuhs.ac; beomkkim@yuhs.ac;psyoung0419@gmail.com; KSUKOREA@yuhs.ac; sikarue@yuhs.ac;sinndhn@hanmail.net;psyoung0419@gmail.com;HJSHIN105@yuhs.ac;lorry-lee@yuhs.ac;beomkkim@yuhs.ac;drpjy@yuhs.ac;dyk1025@yuhs.ac;ahnsh@yuhs.ac;mdflorence@yuhs.ac;ksukorea@yuhs.ac; jenny.yang@gilead.com; umsh@korea.ac.kr; |
||
|
Bacon, Bruce (Bacon, B) |
St Louis Univ, Sch Med, St Louis, MO USA |
AAD-6897-2021 Simona, Gheorghe |
|
[JCR상위 4.8] Efficacy, safety, and tolerability of seladelpar in patients with compensated liver cirrhosis due to primary biliary cholangitis (PBC): a pooled analysis of phase 2 and phase 3 studies | SCIE | 4.8 | GASTROENTEROLOGY & HEPATOLOGY | ychoi@cymabay.com; | ||
|
Beom, Jong Wook (Beom, JW) |
Jeju Natl Univ Hosp, Dept Internal Med, Jeju, South Korea |
|
|
[JCR상위 4.8] Effect of beta-blocker therapy in patients with or without left ventricular systolic dysfunction after acute myocardial infarction | SCIE | 4.8 | CARDIAC & CARDIOVASCULAR SYSTEMS;PHARMACOLOGY & PHARMACY | sejjoo@jejunu.ac.kr; | ||
|
Berg, Thomas (Berg, T) |
Univ Leipzig, Dept Med 2, Div Hepatol, Med Ctr, Leipzig, Germany Univ Leipzig, Med Ctr, Div Hepatol, Dept Med 2, Leipzig, Germany |
|
|
[JCR상위 4.8] The artificial intelligence-driven model for prediction of hepatocellular carcinoma development in chronic hepatitis B patients: Derivation and validation using 11, 111 patients from Asian and Caucasian cohorts [JCR상위 5.9] IMPACT OF HBEAG ON HEPATOCELLULAR CARCINOMA RISK DURING ORAL ANTIVIRAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B |
SCIE | 4.8 | GASTROENTEROLOGY & HEPATOLOGY | pindra@empal.com; | ||
|
Bezerra, Jorge (Bezerra, J) |
Cincinnati Childrens Hosp, Cincinnati, OH USA |
|
|
[JCR상위 4.8] Long-term Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Children with Chronic Hepatitis B (CHB): Final Results from a Placebo-Controlled Trial | SCIE | 4.8 | GASTROENTEROLOGY & HEPATOLOGY | john.flaherty@gilead.com; | ||
|
Borg, Brian (Borg, B) |
Jackson Liver & GI Specialists, Jackson, MS USA |
A-5512-2011 Borg, Brian |
|
[JCR상위 4.8] Efficacy, safety, and tolerability of seladelpar in patients with compensated liver cirrhosis due to primary biliary cholangitis (PBC): a pooled analysis of phase 2 and phase 3 studies | SCIE | 4.8 | GASTROENTEROLOGY & HEPATOLOGY | ychoi@cymabay.com; | ||
|
Bowlus, Christopher (Bowlus, C) |
Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA |
N-9276-2016 Bowlus, Christopher |
|
[JCR상위 4.8] Efficacy, safety, and tolerability of seladelpar in patients with compensated liver cirrhosis due to primary biliary cholangitis (PBC): a pooled analysis of phase 2 and phase 3 studies | SCIE | 4.8 | GASTROENTEROLOGY & HEPATOLOGY | ychoi@cymabay.com; | ||
|
Buti, Maria (Buti, M) |
Hosp Gen Univ Vall Hebron, Barcelona, Spain Ciberehd, Barcelona, Spain Hosp Univ Vall Dhebron, Dept Internal Med, Liver Unit, Barcelona, Spain |
A-5327-2019 Buti, MARIA |
|
[JCR상위 4.8] The artificial intelligence-driven model for prediction of hepatocellular carcinoma development in chronic hepatitis B patients: Derivation and validation using 11, 111 patients from Asian and Caucasian cohorts [JCR상위 5.9] IMPACT OF HBEAG ON HEPATOCELLULAR CARCINOMA RISK DURING ORAL ANTIVIRAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B |
SCIE | 4.8 | GASTROENTEROLOGY & HEPATOLOGY | pindra@empal.com; | ||
|
Byun, Kwan Soo (Byun, KS) |
Korea Univ, Coll Med, Guro Hosp, Seoul, South Korea |
|
|
[JCR상위 4.8] Safety, efficacy, and pharmacodynamic (PD) activity of 12 weeks treatment with oral RIG-I agonist, inarigivir (IRIG), plus 48 weeks of tenofovir alafenamide in adult patients with chronic hepatitis B: a phase 2 collaboration study | SCIE | 4.8 | GASTROENTEROLOGY & HEPATOLOGY | jenny.yang@gilead.com; | ||
|
Calleja Panero, Jose Luis (Panero, JLC) |
Hosp Univ Puerta Hierro, IDIPHIM, CIBERehd, Barcelona, Spain |
A-5351-2010 Panero, Jose |
|
[JCR상위 4.8] The artificial intelligence-driven model for prediction of hepatocellular carcinoma development in chronic hepatitis B patients: Derivation and validation using 11, 111 patients from Asian and Caucasian cohorts | SCIE | 4.8 | GASTROENTEROLOGY & HEPATOLOGY | pindra@empal.com; | ||
|
Chan, Henry L. Y. (Chan, HLY) |
Prince Wales Hosp, Hong Kong, Peoples R China |
B-9636-2008 Chan, Henry |
|
[JCR상위 4.8] Safety, efficacy, and pharmacodynamic (PD) activity of 12 weeks treatment with oral RIG-I agonist, inarigivir (IRIG), plus 48 weeks of tenofovir alafenamide in adult patients with chronic hepatitis B: a phase 2 collaboration study | SCIE | 4.8 | GASTROENTEROLOGY & HEPATOLOGY | jenny.yang@gilead.com; | ||
|
Chang, Mei-Hwei (Chang, MH) |
제1저자 | Natl Taiwan Univ Hosp, Taipei, Taiwan |
|
|
[JCR상위 4.8] Long-term Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Children with Chronic Hepatitis B (CHB): Final Results from a Placebo-Controlled Trial | SCIE | 4.8 | GASTROENTEROLOGY & HEPATOLOGY | john.flaherty@gilead.com; | |
|
Chen, Diana (Chen, D) |
Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA |
|
|
[JCR상위 4.8] Safety, efficacy, and pharmacodynamic (PD) activity of 12 weeks treatment with oral RIG-I agonist, inarigivir (IRIG), plus 48 weeks of tenofovir alafenamide in adult patients with chronic hepatitis B: a phase 2 collaboration study | SCIE | 4.8 | GASTROENTEROLOGY & HEPATOLOGY | jenny.yang@gilead.com; |
페이지 이동: